Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 6;10(9):1243.
doi: 10.3390/nu10091243.

Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer's Disease: A Mendelian Randomization Study

Susanna C Larsson  1 , Matthew Traylor  2 , Hugh S Markus  3 , Karl Michaëlsson  4
Affiliations

Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer's Disease: A Mendelian Randomization Study

Susanna C Larsson et al. Nutrients. .

Abstract

We conducted Mendelian randomization analyses to investigate the associations of serum parathyroid hormone (S-PTH) and serum 25-hydroxyvitamin D (S-25OHD) concentrations with Alzheimer's disease (AD). Five and seven single nucleotide polymorphisms associated with S-PTH and S-25OHD concentrations, respectively, were used as instrumental variables. Data for AD were acquired from the International Genomics of Alzheimer's Project (17,008 AD cases and 37,154 controls). Genetically higher S-PTH concentrations were not associated with AD (odds ratio per standard deviation increase in S-PTH = 1.11; 95% CI 0.97⁻1.26; p = 0.12). In contrast, all seven 25OHD-increasing alleles were inversely associated with AD and two of the associations were statistically significant (p < 0.05). The odds ratio of AD per genetically-predicted one standard deviation increase in S-25OHD was 0.86 (95% CI 0.78⁻0.94; p = 0.002). This study provides evidence that vitamin D may play a role in AD but found no significant association between S-PTH and AD.

Keywords: Alzheimer’s disease; Mendelian randomization; parathyroid hormone; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Association between a genetically-predicted one standard deviation increase of S-PTH concentration and AD.
Figure 2
Figure 2
Association between a genetically predicted one standard deviation increase of S-25OHD concentration and Alzheimer’s disease. rs1968487 was used as proxy SNP for rs10745742 (r2 between these two SNPs = 1.0).
See this image and copyright information in PMC

References

    1. Holick M.F. Vitamin D and brain health: The need for vitamin D supplementation and sensible sun exposure. J. Intern. Med. 2015;277:90–93. doi: 10.1111/joim.12308. - DOI - PubMed
    1. Annweiler C., Dursun E., Feron F., Gezen-Ak D., Kalueff A.V., Littlejohns T., Llewellyn D.J., Millet P., Scott T., Tucker K.L., et al. ‘Vitamin D and cognition in older adults’: Updated international recommendations. J. Intern. Med. 2015;277:45–57. doi: 10.1111/joim.12279. - DOI - PubMed
    1. Morello M., Landel V., Lacassagne E., Baranger K., Annweiler C., Feron F., Millet P. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer’s Disease. Mol. Neurobiol. 2018;55:3463–6479. doi: 10.1007/s12035-017-0839-1. - DOI - PMC - PubMed
    1. Durk M.R., Han K., Chow E.C., Ahrens R., Henderson J.T., Fraser P.E., Pang K.S. 1alpha, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-beta accumulation and improves cognition in mouse models of Alzheimer’s disease. J. Neurosci. 2014;34:7091–7101. doi: 10.1523/JNEUROSCI.2711-13.2014. - DOI - PMC - PubMed
    1. Keeney J.T., Butterfield D.A. Vitamin D deficiency and Alzheimer disease: Common links. Neurobiol. Dis. 2015;84:84–98. doi: 10.1016/j.nbd.2015.06.020. - DOI - PubMed

Grants and funding

LinkOut - more resources